Fasting Bioequivalence Study of 2 Metformin 500 mg Prolonged Release Tablets in 44 Healthy Male and Female Volunteers
Status:
Completed
Trial end date:
2021-05-29
Target enrollment:
Participant gender:
Summary
This study was designed to compare the bioavailability of the Test Product Metformin 500mg
Prolonged Release Tablets (JSC Farmak, Ukraine) and Reference Product Glucophage® XR 500 mg
Prolonged Release Tablets (Merck Serono Ltd, UK) in healthy male and female volunteers under
fasting conditions.